Newsroom Newsroom Press Releases Events & Presentations News Articles Media Center Recent Press Releases February 27, 2025 Frontier Medicines to Participate in Two Upcoming March Investor Conferences View Release January 9, 2025 Frontier Medicines Announces FMC-220, the First Covalent p53 Y220C Activator Development Candidate, with Best-in-Class Potential View Release January 8, 2025 Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference View Release Read All Press Releases Events & Presentations UPCOMING EVENTS There are currently no upcoming events scheduled Select Media Coverage April 11, 2024 Fierce Biotech: AACR: Verastem, Quanta and Frontier demonstrate KRAS inhibitors' potential in preclinical data Read Article February 22, 2024 Fierce Biotech: Frontier CEO weathers 'one of the hardest financings' of his career to close $80M series C Read Article February 22, 2024 San Francisco Business Times: Peninsula biotech raises $80M as it doses 1st person in 1st clinical trial Read Article Read All News Media Center Media Contact Contact PR Team Logos Click on the links below to download a high resolution image of the Frontier Medicines logo Download Image Download Image Download Image Download Image
February 27, 2025 Frontier Medicines to Participate in Two Upcoming March Investor Conferences View Release
January 9, 2025 Frontier Medicines Announces FMC-220, the First Covalent p53 Y220C Activator Development Candidate, with Best-in-Class Potential View Release
January 8, 2025 Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference View Release
April 11, 2024 Fierce Biotech: AACR: Verastem, Quanta and Frontier demonstrate KRAS inhibitors' potential in preclinical data Read Article
February 22, 2024 Fierce Biotech: Frontier CEO weathers 'one of the hardest financings' of his career to close $80M series C Read Article
February 22, 2024 San Francisco Business Times: Peninsula biotech raises $80M as it doses 1st person in 1st clinical trial Read Article